Experimental and clinical observations of 99mTc-MIBI uptake correlate with P-glycoprotein expression in lung cancer

Nuclear Medicine Communications

Volumn 28, Issue 9, 2007, Pages 696-703

  Yang, Aimin ^a   Xue, Jianjun ^a   Li, Xu ^a   Yu, Yan ^a   Deng, Huixing ^a   Hu, Guoyimg ^b   Meng, Xianwen ^b   Li, Jie ^b  

^a Department of Nuclear Medicine ^*  (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Lung cancer; MDR; SPECT; Tumour

Indexed keywords

GLYCOPROTEIN P; MALONIC ACID; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; POTASSIUM;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DRUG UPTAKE; FEMALE; HUMAN; HYPERPOLARIZATION; LUNG CANCER; LUNG FIBROBLAST; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; P-GLYCOPROTEIN; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 34547676290     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3281f74d97     Document Type: Article

References (31)

1. Wackers FJ, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, et al. Technetium-99m-hexakis-2-methoxyisobutylisonitrile: human distribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30:301-311.
2. Muller ST, Guth-Tougeides B, Creutzig H. Imaging of malignant tumor with Tc-99m-MIBI SPECT. J Nucl Med 1987; 284:562.
3. Balon HR, Fink-Bennett D, Stoffer SS. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid. J Nucl Med 1992; 7:1393-1395.
4. 99mTc]MIBI in benign and malignant lesions in the lungs. Clin Nucl Med 1989; 14:333-340.
5. Caner B, Kitapci M, Aras T, Erbengi G, Ugur O, Bekdik C. Increased accumulation of hexakis(2-methoxyisobutylisonitrile) technetium in osteosarcoma and its metastatic lymph nodes. J Nucl Med 1991; 32:1977-1978.
6. Scott AM, Kostakoglu L, Brien JP, Straus DJ, Abdel-Dayem HM, Larson SM. Comparison of technetium-99m-MIBI and thallium-201 chloride uptake in primary thyroid lymphoma. J Nucl Med 1992; 33:1396-1398.
7. Shih WJ, Ashford JW, Coupal JJ, Ryo YU, Stipp VV, Magoun SL, Gross K. Consecutive brain SPECT surface three-dimensional displays show progression of cerebral cortical abnormalities in Alzheimer's disease. Clin Nucl Med 1999; 24:773-777.
8. 99mTc-MIBI single-photon emission-computed tomography in diagnosis of lung cancer and mediastinal metastasis lymph nodes. J Chin Pharmacol 1999; 20:800-804.
9. 99mTc image agent for P-gp imaging. Journal of Foreign Medicine 1999; 23:206-208.
10. Mousa SA, Maina M, Brown BA, Williams SJ. Retention of RO-30 in the heart may be due to binding to a cytosolic protein. J Nucl Med 1987; 28:619.
11. Mousa SA, Williams SJ, Sands H. Characterization of in vivo chemistry of cations in the heart. J Nucl Med 1987; 28:1351-1357.
12. Piwnica-Worms D, Kronauge F, Holman L, Davison A, Jones AG. Comparative myocardial uptake characteristics of hexakis (alkylisonitrile) technetium (I) complexes: effect of lipophilicity. Invest Radiol 1989; 24:25-29.
13. 99mTc-MIBI imaging on pulmonary cancer. Chin J Nucl Med 1993; 13:194-195.
14. Chiti A, Maffioli LS, Infante M, Graselli G, Incarbone M, Gasparini MD, et al. Assessment of mediastinal involvement in lung cancer with Tc-99m-sestamibi SPECT. J Nucl Med 1996; 37:938-942.
15. 99mTc-MIBI tomography on P-gp qualitative evaluation in lung tumors. Chin J Nucl Med 1998; 18:32-34.
16. Zhu Z, Li F, Li L, Chen F. The clinic character and value of the technetium-99m-MIBI first pass imaging on the lung occupied lesions. Chin J Nucl Med 1999; 19:119-120.
17. 99mTc by human carcinoma cell lines in vitro. Cancer Res 1990; 50:2198-2202.
18. Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, Piwnica-Worms D. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992; 33:1516-1521.
19. Hunan Medical College. Physiology. Peoples Hygiene Publication Corporation; 1978. pp. 20-28.
20. Zhou AB. Biochemistry. Chemistry and Industry Publication Corporation; 1989. pp. 90-92.
21. Maublant JC, Zhang Z, Rapp M, Ollier M, Michelot J, Veyre A. In vitro Uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: Comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med 1993; 34:1949-1952.
22. m-MIBI semi-quantitative image for thyroid nodules. Chin Nucl Med 2002; 22:112-113.
23. Scott AM, Kostakoglu L, O'Brien JP, Straus DJ, Abdel-Dayem HM, Larson SM. Comparison of technetium-99m-MIBI and thallium-201 chloride uptake in primary thyroid lymphoma. J Nucl Med 1992; 33:1396-1398.
24. Baekelandt MM, Holm R, Nesland JM, Trope CG, Kristensen GB. P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advance ovarian cancer. Anticancer Res 2000; 20:1061-1067.
25. Caaitrot Y, Bichat F, Cole SP, Deeley RG, Gerlach JH, Bastian G. Multidrug resistance genes (MRP) and MDRl expression in small cell lung cancer xenografts: relationship with response to chemotherapy. Cancer Lett 1999; 130:133-141.
26. Young LC, Campling BG, Voskoglou-Nomikos T, Cole SP, Deeley RG, Gerlach JH. Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response. Clin Cancer Res 1999; 5:673-680.
27. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993; 53:977-984.
28. Moretti JL, Duran Cordobes M, Starzec A, De Beco V, Vergote J, Benazzouz F. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells. J Nucl Med 1998; 39:1214-1218.
29. Soluri A, Scopinaro F, De Vincentis G, Varvarigou A, Scafe R, Massa R, et al. 99MTC [13LEU] bombesin and a new gamma camera, the imaging probe, are able to guide mammotome breast biopsy. Anticancer Res 2003; 23:2139-2142.
30. Bom HS, Kim JY, Kim YC, Choi IS, Park KO. Tc-99m MIBI uptake in simultaneous thyroid and lung cancers. Clin Nucl Med 1994; 9:604-606.
31. Kao A, Shiun SC, Hsu NY, Sun SS, Lee CC, Lin CC. Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression. Ann Oncol 2001; 12:1561-1566.